Resistance to Proteasome Inhibitors in Cancer Molecular Mechanisms and Strategies to Overcome Resistance /
The book explores cutting-edge strategies to overcome proteasome inhibitor resistance, including the second generation 20S proteasome inhibitors, novel combinational therapies, and new targets in the ubiquitin-proteasome pathway (e.g., ubiquitin E3 ligases, deubiquitinases, 19S proteasomal ATPases,...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | SpringerLink (Online service) |
Otros Autores: | Dou, Q. Ping (Editor ) |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2014.
|
Edición: | 1st ed. 2014. |
Colección: | Resistance to Targeted Anti-Cancer Therapeutics,
|
Temas: | |
Acceso en línea: | Texto Completo |
Ejemplares similares
-
Resistance to Aromatase Inhibitors in Breast Cancer
Publicado: (2015) -
PARP Inhibitors for Cancer Therapy
Publicado: (2015) -
BRAF Targets in Melanoma Biological Mechanisms, Resistance, and Drug Discovery /
Publicado: (2015) -
Nitric Oxide and Cancer: Pathogenesis and Therapy
Publicado: (2015) -
Resistance to Photodynamic Therapy in Cancer
Publicado: (2015)